CStone Pharmaceuticals announced the appointment of Ms. Shirley Zhao to the position of General Manager for Greater China and Head of Commercial. In this position, Ms. Zhao will be responsible for the commercialization of the Company's products and will report directly to Dr. Frank Jiang, Chairman and CEO of CStone. Ms. Zhao is a seasoned industry leader with over 26 years of experience working at multiple multinational biopharmaceutical companies. Equipped with exceptional business acumen and strategic thinking, Ms. Zhao has effectively executed numerous critical initiatives. Before joining CStone, Ms. Zhao was the Country GM for Bristol-Myers Squibb (BMS) China, where she successfully led the launch of Opdivo®, the first anti-PD-1 antibody to enter the China market. Prior to BMS, Ms. Zhao served as Country GM at Genzyme and Allergan.